Cargando…
Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities
Targeted therapies have become an important therapeutic paradigm for multiple malignancies. The rapid development of resistance to these therapies impedes the successful management of advanced cancer. Due to the redundancy in angiogenic signaling, alternative proangiogenic factors are activated upon...
Autores principales: | Sharan, Satish, Woo, Sukyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335258/ https://www.ncbi.nlm.nih.gov/pubmed/25750626 http://dx.doi.org/10.3389/fphar.2015.00033 |
Ejemplares similares
-
Quantitative Insight in Utilizing Circulating Angiogenic Factors as Biomarkers for Antiangiogenic Therapy: Systems Pharmacology Approach
por: Sharan, S, et al.
Publicado: (2014) -
μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023) -
Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches
por: Ribba, Benjamin, et al.
Publicado: (2023) -
Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical Studies
por: Tian, Hui, et al.
Publicado: (2021) -
Challenges and Opportunities of Nanotechnology as Delivery Platform for Tocotrienols in Cancer Therapy
por: Maniam, Geetha, et al.
Publicado: (2018)